GORDON CARL L (CIK 1282930) reported 8 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2025-12-18). Recent activity: Sell KROS (140,057 shares), Sell KROS (74,465 shares), Buy KROS (5,250 shares), Sell CMPX (3.6M shares), Buy MBX (17,962 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-18 | Keros Therapeutics, Inc. (KROS) | Director | Sell | 140,057 | $2.5M |
| 2025-12-18 | Keros Therapeutics, Inc. (KROS) | Director | Sell | 74,465 | $1.3M |
| 2025-06-06 | Keros Therapeutics, Inc. (KROS) | Director | Buy | 5,250 | $0 |
| 2025-04-11 | Compass Therapeutics, Inc. (CMPX) | Director | Sell | 3.6M | $5.7M |
| 2025-02-19 | MBX Biosciences, Inc. (MBX) | Director | Buy | 17,962 | $177,824 |
| 2025-02-19 | MBX Biosciences, Inc. (MBX) | Director | Buy | 29,540 | $290,969 |
| 2025-02-19 | MBX Biosciences, Inc. (MBX) | Director | Buy | 49,070 | $531,919 |
| 2025-02-19 | MBX Biosciences, Inc. (MBX) | Director | Buy | 94,100 | $1.0M |
Source: SEC Form 4 filings · as of 2025-12-18